Seattle, July 16, 2020. Joylux, a leader in high-tech vaginal health and wellness devices and products targeting menopausal women, announced that Dr. Kathy Fields—the cofounder of leading skincare brand Rodan + Field and co-creator of Proactiv—is joining their board of directors.…
Pittsburgh, August 27, 2020 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular damage response pathways announced that it has dosed the first patient in the SEQUEL (Study of EEG QUantification with ELayta) Study of CT1812 (Elayta™) in adults with mild-to-moderate Alzheimer’s disease.…
Sofia portfolio company Cognition Therapeutics awarded $75.8M in competitive grant process, to study efficacy of its technology with early Alzheimer’s patients
New York, June 08, 2020 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in Alzheimer’s disease and other neurodegenerative disorders, today announced that the National Institute on Aging (NIA) of the National Institutes of Health (NIH) has awarded the Company a grant (number R01AG065248) expected to total $75.8 million over five years to support a 540-patient Phase 2 study of CT1812 in individuals with early Alzheimer’s disease.…
Minneapolis, May 2020 – Unique, creative models that connect sellers and buyers are benefitting from the new reality of social distancing. Kidizen, the online community marketplace for second-hand kids’ fashion, is seeing increased engagement in its virtual community and the female founders of the tech startup attribute it to COVID19.…
Smart PPE Patch Monitors and Relays Real-Time Stress Indicators to Protect Workers Against Heat Injuries and Death
New York, May 7, 2020 – Kenzen, the smart PPE innovator focused on physiological monitoring and the prevention of heat injury and death among workers, has launched a real-time worker heat monitoring system.…
Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy RBX2660.
This is a major milestone in Rebiotix’s efforts to bring the first microbiota-based therapeutic to the market to treat people that have recurrent Clostridioides difficile infection (rCDI).…
Sofia Fund’s Cathy Connett and Sofia Fund’s portfolio company StormSensor’s Erin Rothman offer tips on finding each other.
“Potential investors want to know that you can take this on, that you will push it across the finish line, that you have the vision and the skills necessary to make the company thrive by building the right team and product.…
Chicago’s Midwest Orthopedics at Rush, one of the leading orthopedic clinics in the country, has adopted Oculogica’s EyeBOX® for concussion assessments. EyeBOX is the first FDA authorized diagnostic for concussion that does not require a baseline test.
Full press release here: https://www.prnewswire.…
Health care drew huge venture-capital investments in 2019.
“In 2020, venture-capital firms, including Twin Cities-based Rally Ventures, the most active in Minnesota, and female-led Sofia Fund, deployed $136.5 billion in U.S. companies, surpassing the $130 billion mark for the second consecutive year, according to the January-released PitchBook-National Venture Capital Association (NVCA) Venture Monitor.”…
Sofia Fund invests along with Pearson Ventures in an ed-tech start up focused on bringing current content to health care professionals in an easy to use, on-line format that improves retention and the knowledge base.